Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3710262013 | Heparinoid- and salicylic acid-containing product in transdermal dose form | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 3710263015 | Product containing heparinoid and salicylic acid in transdermal dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing heparinoid and salicylic acid in transdermal dose form (medicinal product form) | Is a | Product containing heparinoid | false | Inferred relationship | Existential restriction modifier | ||
| Product containing heparinoid and salicylic acid in transdermal dose form (medicinal product form) | Has manufactured dose form | Transdermal dose form | true | Inferred relationship | Existential restriction modifier | ||
| Product containing heparinoid and salicylic acid in transdermal dose form (medicinal product form) | Is a | Product manufactured as transdermal dose form | true | Inferred relationship | Existential restriction modifier | ||
| Product containing heparinoid and salicylic acid in transdermal dose form (medicinal product form) | Has active ingredient | Salicylic acid | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing heparinoid and salicylic acid in transdermal dose form (medicinal product form) | Is a | Product containing salicylic acid | false | Inferred relationship | Existential restriction modifier | ||
| Product containing heparinoid and salicylic acid in transdermal dose form (medicinal product form) | Has active ingredient | Heparinoid | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing heparinoid and salicylic acid in transdermal dose form (medicinal product form) | Is a | Product containing heparinoid and salicylic acid (medicinal product) | true | Inferred relationship | Existential restriction modifier | ||
| Product containing heparinoid and salicylic acid in transdermal dose form (medicinal product form) | Plays role | Antifungal therapeutic role | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release transdermal cream | Is a | False | Product containing heparinoid and salicylic acid in transdermal dose form (medicinal product form) | Inferred relationship | Existential restriction modifier | |
| Product containing only heparinoid and salicylic acid in transdermal dose form (medicinal product form) | Is a | True | Product containing heparinoid and salicylic acid in transdermal dose form (medicinal product form) | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR